Rocío Ferreiro-Iglesias

14PUBLICATIONS
105CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Nutritional epidemiologyPredictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.

Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz

|Sep 29, 2025
Effectiveness and safety of dual advanced therapy in inflammatory bowel disease: a multicenter series from Galicia, Spain.

M ª Teresa Diz-Lois Palomares, Carmen Pradera Cibreiro, Carmen Cabezal Iglesias

|Apr 10, 2025
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU.

Esteban Fuentes-Valenzuela, Iria Bastón-Rey, Francisco Javier García-Alonso

|Apr 01, 2025
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study.

Daniele Noviello, María Chaparro, Chiara Viganò

|Jan 18, 2025
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study.

Offir Ukashi, Aurelien Amiot, David Laharie

|Jun 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín

Pageof 3

Frequent Collaborators

9 joint publications

Manuel Barreiro-de Acosta

5 joint publications

Yamile Zabana

4 joint publications

María Chaparro

4 joint publications

Javier Pérez Gisbert